Literature DB >> 4655287

Pharmacokinetics of fentanyl in man and the rabbit.

R Hess, G Stiebler, A Herz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4655287     DOI: 10.1007/bf00561135

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  10 in total

1.  A STUDY OF SOME OF THE PHARMACOLOGIC ACTIONS OF FENTANYL CITRATE.

Authors:  J F GARDOCKI; J YELNOSKY
Journal:  Toxicol Appl Pharmacol       Date:  1964-01       Impact factor: 4.219

2.  ["NEUROLEPTANALGESIA"].

Authors:  H KREUSCHER
Journal:  Dtsch Med Wochenschr       Date:  1965-04-16       Impact factor: 0.628

3.  The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawl reflex in rats.

Authors:  P A JANSSEN; C J NIEMEGEERS; J G DONY
Journal:  Arzneimittelforschung       Date:  1963-06

4.  A narcotic analgesic and a butyrophenone with nitrous oxide for general anesthesia.

Authors:  M C HOLDERNESS; P E CHASE; R D DRIPPS
Journal:  Anesthesiology       Date:  1963 May-Jun       Impact factor: 7.892

5.  [Permeation of active morphine-like substances at their sites of antinociceptive action in the brain as a function of their lipid-solubility following intravenous and intraventricular application].

Authors:  B von Cube; H Teschemacher; A Herz; R Hess
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1970

6.  Clinical investigation of the analgesic potency and respiratory depressant activity of fentanyl, a new narcotic analgesic.

Authors:  J S Finch; T J DeKornfeld
Journal:  J Clin Pharmacol J New Drugs       Date:  1967 Jan-Feb

7.  Pharmacokinetics of fentanyl in rabbits in view of the importance for limiting the effect.

Authors:  R Hess; A Herz; K Friedel
Journal:  J Pharmacol Exp Ther       Date:  1971-12       Impact factor: 4.030

8.  Studies on the fate of fentanyl.

Authors:  Y Maruyama; E Hosoya
Journal:  Keio J Med       Date:  1969-06

9.  [Neuroleptoanalgesia].

Authors:  W F Henschel
Journal:  Landarzt       Date:  1966-12-31

10.  The magnitude and duration of respiratory depression due to fentanyl and meperidine in man.

Authors:  J J Downes; R A Kemp; C J Lambertsen
Journal:  J Pharmacol Exp Ther       Date:  1967-12       Impact factor: 4.030

  10 in total
  8 in total

1.  Pharmacokinetics of intravenous anaesthetics: implications for clinical use.

Authors:  M M Ghoneim; K Korttila
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

2.  Delayed respiratory depression with fentanyl.

Authors:  J Smydo
Journal:  Anesth Prog       Date:  1979 Mar-Apr

3.  Pharmacokinetics of mestranol in man in relation to its oestrogenic activity.

Authors:  H M Bolt; W H Bolt
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

4.  Perfusion of the fourth cerebral ventricle with fentanyl induces naloxone-reversible bradycardia, hypotension, and EEG synchronisation in conscious dogs.

Authors:  E Freye; J O Arndt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-06       Impact factor: 3.000

Review 5.  Clinical pharmacokinetics of fentanyl and its newer derivatives.

Authors:  L E Mather
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

6.  Fentanyl, rather than Tramadol: A cause of respiratory depression.

Authors:  Ghansham Biyani; Sadik Mohammed; Pradeep Bhatia
Journal:  Indian J Anaesth       Date:  2012-01

7.  The use of fentanyl in pain management in head and neck cancer patients: a narrative review.

Authors:  Raffaele Giusti; Paolo Bossi; Marco Mazzotta; Marco Filetti; Daniela Iacono; Paolo Marchetti
Journal:  Br J Pain       Date:  2017-10-10

8.  Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada.

Authors:  Ashraf Amlani; Geoff McKee; Noren Khamis; Geetha Raghukumar; Erica Tsang; Jane A Buxton
Journal:  Harm Reduct J       Date:  2015-11-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.